/
RSS Feed
SAN DIEGO–(BUSINESS WIRE)–#opioid–Ensysce Biosciences, Inc., a clinical stage drug delivery company, focusing on reducing deaths from opioid use, today announced that D. Lynn Kirkpatrick, Ph.D., Chief Executive Officer, will present at the Janney Healthcare Conference 2019 in New York on Monday September 9, at 8:15 am EST. Dr. Kirkpatrick will discuss the company?s two new classes of opioids, TAAP? and MPAR? technologies that can help to prevent the current crises of prescription drug abuse and overd
